|
USP32 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.575190E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.222700E-04 |
| Normal-vs-Stage2 |
4.857900E-02 |
| Normal-vs-Stage3 |
1.002100E-04 |
| Normal-vs-Stage4 |
1.988000E-04 |
| Stage1-vs-Stage2 |
4.389400E-01 |
| Stage1-vs-Stage3 |
3.593600E-01 |
| Stage1-vs-Stage4 |
2.852800E-01 |
| Stage2-vs-Stage3 |
1.708250E-01 |
| Stage2-vs-Stage4 |
1.640160E-01 |
| Stage3-vs-Stage4 |
8.439800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.158510E-04 |
| Normal-vs-AfricanAmerican |
2.768600E-01 |
| Normal-vs-Asian |
9.444800E-03 |
| Caucasian-vs-AfricanAmerican |
1.249240E-01 |
| Caucasian-vs-Asian |
7.083800E-01 |
| AfricanAmerican-vs-Asian |
2.872000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.36270000000916E-06 |
| Normal-vs-Female |
1.096980E-03 |
| Male-vs-Female |
5.765600E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.081000E-03 |
| Normal-vs-Age(41-60Yrs) |
1.405480E-04 |
| Normal-vs-Age(61-80Yrs) |
3.602200E-04 |
| Normal-vs-Age(81-100Yrs) |
2.039600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.307800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.846800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.900200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.605000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.403200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.618200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.373000E-01 |
| Classical-VS-Follicular |
4.503400E-01 |
| Classical-VS-Other |
2.144000E-01 |
| Classical-VS-Normal |
1.220960E-03 |
| Tall-VS-Follicular |
9.131000E-01 |
| Tall-VS-Other |
3.039800E-01 |
| Tall-VS-Normal |
5.441100E-03 |
| Follicular-VS-Other |
3.888000E-01 |
| Follicular-VS-Normal |
2.404300E-03 |
| Other-VS-Normal |
1.516380E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.634900E-04 |
| Normal-vs-N1 |
1.198500E-03 |
| N0-vs-N1 |
6.101800E-01 |
|
|
